ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
The Evolving Role of the Patient in Clinical Trials
A ‘review of the year’ thought leadership article, authored by Gretchen Goller, discussing the changing role of the patient throughout 2019.
Using Historical Controls for Rare Disease Trials: Challenges and Opportunities
The use of historical controls in rare disease trials, using existing medical history information on a group of similar patients
Transforming Clinical Trials with Digital Tech, and what that means for the Patient
A thought leadership article exploring the evolving role of technology in the clinical trials arena and the importance prioritising the integration and interrelation of technology in 2020.
The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
An article featuring commentary by Andrew Garrett, discussing the importance of navigating through the hype surrounding AI and the ways in which the Pharma industry can manage expectations.
Innovation in Oncology Drug Development
This Journal of Oncology article highlights recent, innovative changes that are occurring in oncology clinical trial development.
Intricacies of Precision Medicine for Biotechs
Andrew Garrett discusses challenges such as patient recruitment for biotechs developing therapies for targeted populations with rare diseases.
Navigating an Ever Evolving Regulatory and Pharmacovigilance Landscape
Chuhua Wu outlines the variations in the structures, processes and outcomes of pharmacovigilance status among Asian countries.
The Danger of 'Going too far' with AI
Andrew Garrett spoke on a panel at the Financial Times Pharmaceutical & Biotechnology conference, about the recent integration of artificial intelligence (AI) enabled services in pharma R&D.
Risk-Based Monitoring and Real-World Data: A Decentralised Ecosystem
Ian O'Shaughnessy considers how to ensure a reality for the bright future of digitisation as clinical trials evolve.
Trends in Payer Reliance on ICER Assessments
A thought leadership authored by Jenny Lee and Eric Latch, based on the ICON’s whitepaper “Payer reliance on ICER assessments and perceptions on value-based pricing”.